Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial

INTRODUCTION: This study aimed to evaluate the short-term cost-effectiveness of insulin degludec 200 units/mL (degludec) versus insulin glargine 300 units/mL (glargine U300) from a Dutch societal perspective. METHODS: A previously published model estimated costs [2018 euros (EUR)] and effectiveness...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Adv Ther
Egile Nagusiak: Evans, Marc, Moes, Robert G. J., Pedersen, Katrine S., Gundgaard, Jens, Pieber, Thomas R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7467476/
https://ncbi.nlm.nih.gov/pubmed/32306247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01332-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak